AVGO vs INLX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Broadcom exhibits a dichotomy between elite operational performance and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable health, the stock trades at a massive premium to its Graham Number ($44.08) and Intrinsic Value ($151.04). This valuation gap is partially justified by a very attractive PEG ratio (0.68) and strong forward P/E (19.65), suggesting high growth expectations. However, aggressive insider selling by the CEO and CFO, combined with a bearish technical trend, offsets the strong analyst 'strong_buy' consensus.
The company exhibits severe financial weakness, highlighted by a Piotroski F-Score of 2/9, placing it firmly in the 'Weak' health category. Despite a strong gross margin of 66.05%, the business is struggling with stagnant revenue growth (1.00% YoY) and negative profitability (ROE -17.01%). The technical trend is completely bearish (0/100), and the stock has lost over 53% of its value in the last year. With a Forward P/E of 116.67 and no meaningful growth catalysts, the current valuation is difficult to justify.
Compare Another Pair
Related Comparisons
AVGO vs INLX: Head-to-Head Comparison
This page compares Broadcom Inc. (AVGO) and Intellinetics, Inc. (INLX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.